The Centre has appointed Piyush Singla as Director in the NHA under the Ayushman Bharat Digital Mission (ABDM), further strengthening leadership in India’s rapidly expanding digital healthcare ecosystem. Dr. Singla is a 2012-batch IAS officer from the AGMUT cadre and was recommended for Central deputation by
Patient safety is, and will always remain, Lilly’s highest priority Eli Lilly and Company (India) commends the actions taken by the Haryana drug control authority in addressing counterfeit products falsely bearing the Mounjaro® (tirzepatide) brand name that were recently seized in Gurugram, Haryana. These seized counterfeit
Rubicon Research Limited (“Rubicon” or the “Company”) today announced the acquisition of an 85% equity ownership in Arinna Lifesciences Limited (“Arinna”) from its current shareholders. With a portfolio of over 60 brands in chronic therapies, Arinna is one of the few domestic formulations companies principally focused
In a move to strengthen drug regulation and ensure the availability of safe, high-quality medicines, Uttar Pradesh Chief Minister Yogi Adityanath announced that the state government will double the number of drug inspectors across the state. The decision is aimed at improving the monitoring of
Democratizes healthcare access for India's 700+ million non-English speaking population. Today, Artificial Intelligence (AI) is making inroads in almost all industries and healthcare is seeing an increasing use of this in diagnosis, risk assessment, surgeries and more. In this scenario, we now have the AI Triage Solution, a
Torrent Pharmaceuticals Ltd. (NSE: TORNTPHARM / BSE: 500420) has announced the launch of Shelcal® Total, a scientifically formulated adult nutrition supplement powder that expands its flagship Shelcal® brand into the rapidly growing Nutrition segment. Shelcal®—with a three-decade legacy of trust—has remained India’s #1 calcium supplement brand
One of the most engaging highlights at India Health 2025 was the thought-provoking session on “Building the Smart Hospital for the Decade”, which brought together a multidisciplinary panel of experts — from healthcare architects and clinicians to hospital promoters, technologists, and cyber-security professionals. The session
Continues to build a full-stack Ayurveda enterprise with focus on comprehensive precision Ayurveda care and integrative medicine for patients across various clinical conditions Launches 50 SKUs across classical Ayurveda formulations, OTC products, and medical foods Targets nationwide reach and ₹500 crores in Products revenue in the
Primus Partners – India’s leading consultancy – launched its latest thought leadership report, ‘Shaping India’s Future: Healthcare and Social Equity for All by 2047’, outlining a broad roadmap to establish 25 integrated MediCities across India by 2047. Planned as PPP-driven (public-private partnership) healthcare ecosystem, these MediCities
The Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY), India's flagship health insurance scheme, has facilitated over 6.8 million cancer treatments since its inception, with a significant majority of beneficiaries hailing from rural areas, according to Union Health Minister J.P. Nadda. Key Highlights: Total Cancer Treatments: Approximately
